Trial Profile
Evaluation of weekly paclitaxel, carboplatin, and cetuximab in head and neck cancer patients with incurable disease: A Single-center, Retrospective, Observational Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Apr 2017
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Cetuximab (Primary) ; Paclitaxel (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 26 Apr 2017 New trial record